Actionable news
0
All posts from Actionable news
Actionable news in BIIB: Biogen Idec Inc.,

6 Stocks Moving In Tuesday's After-Hours Session

Markets tumbled on Tuesday, driven by weak personal income, inflation and auto sales data out of the U.S.

Shares of Fitbit Inc FIT 3.87%, which were down 3.87 percent during the regular session, rose more than 6 percent in after-hours trading, driven by the announcement of the company’s Q2 results. EPS of $0.12, beating the Street’s consensus by $0.01, while revenue of $586.5 million came in ahead of estimates of $578 million to $580 million. This marks the fifth consecutive quarter where the company managed to outperform top and bottom line expectations.

Electronic Arts Inc. EA 0.2% slipped 1.65 percent after the bell rang, after guidance fell short of expectations. While EPS of $0.07 and revenue of $682 million beat the Street’s consensus by $0.09 and $31.34 million, guidance for the ongoing quarter was disappointing. Management said it expects a net loss of ($0.17) per share on revenue of $915 million, below analysts’ consensus of $0.62 and $1.11 billion.

Tableau Software Inc DATA 0.07% dropped 3.35 percent after the bell rang. Even though revenue of $198.53 million, up 32.5 percent year-over-year, beat the Street’s consensus by $4.78 million, EPS of $0.00 missed expectations by $0.05.

Sturm, Ruger & Company RGR 0.12% gained about 1 percent after-hours,ahead of the announcement of the company’s quarterly financial results.

Etsy Inc ETSY 7.17% was up 5.1 percent even though a second quarter net loss of ($0.06) per share was larger than the anticipated ($0.01) per share. Revenue of $85.35 million implied a 39.1 percent year-over-year increase, and a $4.8 million beat in relation to analyst expectations. Management also raised guidance for full year revenue growth to 25-28 percent, up from 20-25 percent.

Biogen Inc BIIB 9.37% was up slightly driven by takeover speculation. The Wall Street Journal reported both Merck & Co., Inc. MRK 0.56% and Allergan plc Ordinary Shares AGN 1.61% were assessing the possibility.

© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.